1.Lipoproteins and beta-Cell Functions: From Basic to Clinical Data.
Diabetes & Metabolism Journal 2014;38(4):274-277
No abstract available.
Lipoproteins*
2.Study on the effect of antihypertensive drug NHL on some indexes of plasma lipoproteins in patients with hypertention & hyperlipaemia
Journal of Vietnamese Medicine 2005;310(5):38-43
The study was carried out on 39 patients who had hypertension of degree I, II, with lipidemia but without complications to investigate lipoproteins HDL-C, LDL-C of them. The results showed that: concentration of HDL-C increased by 12.5%, concentration of LDL-C decreased by 12.9% (p<0.001) after 30 days of treatment with antihypertensive herbal remedy Nguu tat, Hoe nhai, Linh chi. The results indicated that the remedy had good effects and reduced risk factors of atherosclerosis and hyperlipaemia
Hypertension
;
Lipoproteins
3.The Long and Winding Road: To the Proper Understanding of High-density Lipoprotein
Korean Circulation Journal 2020;50(3):248-249
No abstract available.
Lipoproteins
;
Wind
4.Optimization of the experimental condition on separating lipoproteins by self-constructed asymmetrical flow field-flow fractionation.
Di WU ; Bai Ling QIU ; Chen Qi ZHU ; Shuang GUO ; Ya Ya GAOYANG ; Qi Hui LIANG ; Ye GAO ; Yu SONG ; Nan Yin HAN
Journal of Peking University(Health Sciences) 2018;50(3):564-571
OBJECTIVE:
To analyze and characterize the separation effectiveness of self-constructed asymmetrical flow field-flow fractionation system on proteins and lipoproteins, to achieve the optimization of the experimental conditions when separating lipoproteins by orthogonal design test and to investigate the carrier viscosity's influence on separation effectiveness.
METHODS:
The evaluation of asymmetrical flow field-flow fractionation separation capacity was conducted by using two standard proteins (carbonic anhydrase and thyroglobulin). Under the optimized separation conditions of carbonic anhydrase and thyroglobulin, the channel actual thickness (after assembling, the actual thickness of separation channel was less than initial thickness) was calculated by the analytes' elution time based on the hydrokinetic theory. With orthogonal design test the optimized experimental conditions were studied and statistical analysis was carried on to find out the factors with statistical significance which needed further exploration.
RESULTS:
According to the hydrodynamics principle and Stoke's function, the channel actual thickness was measured to be 164 μm by separating the two standard proteins, carbonic anhydrase and thyroglobulin, under proper experimental conditions. By the optimization based on orthogonal design test, base-line separation (the resolution had to be higher than 1.50) was achieved. The resolutions of the two experiments were 1.61 and 1.58. According to previous study/ pre-study and supporting theory, in the orthogonal design test, the total 5 factors were integrated for comprehensive investigation: the total flow rate (3.00, 3.50, 4.00, 4.50 mL/min), focus time (3.00, 3.50, 4.00, 4.50 min), transition time (0.5, 1.0, 1.5, 2.0 min), pH of the carrier fluid(6.8, 7.00, 7.20, 7.40) and viscosity of the carrier fluid hydroxypropylmethylcellulose concentration: 0.00%, 0.03%, 0.06%, 1.00%). Among the 5 factors, viscosity was found to have the statistical significance on separation effectiveness which was further investigated. The resolution of high density lipoprotein and low density lipoprotein was increased by the increasing viscosity which also caused more obvious negative spikes.
CONCLUSION
The separating capacities of self-constructed asymmetrical flow field-flow fractionation system on lipoproteins were verified to be effective and an optimized experimental condition was found to achieve the base-line separation of high density lipoprotein and low density lipoprotein. Viscosity of the carrier fluid was proved to have the statistical significance on lipoprotein separation.
Fractionation, Field Flow
;
Lipoproteins
;
Lipoproteins, LDL
6.A Study on Serum Lipids and Lipoproteins in Acute Viral Hepatitis in Children.
Journal of the Korean Pediatric Society 1985;28(7):642-652
No abstract available.
Child*
;
Hepatitis*
;
Humans
;
Lipoproteins*
7.Serum lipid, lipoprotein and apoprotein concentrations in diabetic nephropathy.
Kwon Ki KIM ; Yi Sook HWANG ; Jae Hyung AHN ; Tae Won LEE ; Chun Gyoo IHM ; Myung Jae KIM ; Won Do PARK
Korean Journal of Nephrology 1992;11(4):427-436
No abstract available.
Apoproteins*
;
Diabetic Nephropathies*
;
Lipoproteins*
8.Changes of plasma lipoproteins during and after cardiopulmonary bypass.
Jun Young CHOI ; Sang Ho RHIE ; Sung Ho KIM ; Sung Gyu CHUNG ; Chang Soo KIM ; Byung Gyun KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(1):12-17
No abstract available.
Cardiopulmonary Bypass*
;
Lipoproteins*
;
Plasma*
9.Study of Serum Lipids and Lipoprotein in Patients with Nephrotic Syndrome.
Eui Soo PARK ; Jeh Hoon SHIN ; Woo Gill LEE ; Chong Moo PARK
Journal of the Korean Pediatric Society 1983;26(4):349-357
No abstract available.
Humans
;
Lipoproteins*
;
Nephrotic Syndrome*
10.Proliferation and MCP-1 Expression of Vascular Smooth Muscle Cells in Response to Lipoproteins.
Ho Chul PARK ; Young Bok CHANG ; Hoong Zae JOO ; Jae Kyung PARK
Journal of the Korean Society for Vascular Surgery 1999;15(2):177-185
No abstract available.
Lipoproteins*
;
Muscle, Smooth, Vascular*